Interestingly, several loss-of-function mutations in SYN1 and SYN2 genes have been identified in patients suffering of epilepsy and/or autism spectrum disorders (ASD) [10–15] and SYN2 has been identified as one of the highest risk epilepsy genes in a wide screen population [16]. This evidence concerns the gene SYN2 and autism spectrum disorder.